Drug intelligence / Profile preview

ANX776

Development stage
Phase 1
Lead developer
Novai
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

ANX776 is a fluorescently labeled form of the human protein annexin V (also referred to as annexin A5), developed as an intravenous imaging agent for the detection of apoptotic (dying) and stressed retinal cells in vivo. It binds specifically to phosphatidylserine exposed on the surface of apoptosing cells, allowing their visualization using confocal scanning laser ophthalmoscopy. This technology, known as DARC (Detection of Apoptosing Retinal Cells), enables real-time, high-resolution imaging of individual dying retinal ganglion cells in conditions such as glaucoma, age-related macular degeneration (AMD), optic neuritis, and Down’s syndrome. The primary use is diagnostic—to identify early neurodegeneration before functional vision loss occurs and to monitor disease progression or therapeutic response[2][6][7].

Other names
fluorescently labelled annexin Vfluorescently labelled annexin A5
02

Targets

PS (Phosphatidylserine)

Beyond the preview

Go deeper on ANX776.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ANX776.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call